| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.009 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.009 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.086 | 0.009 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.009 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.01 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.01 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.01 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |